EVOGENE LTD. (EVGN) Free cash flow 2016–2025
EVOGENE LTD. (EVGN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$13.6MFY2025 · since FY2016: -$12.5M → -$13.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$13.6M | +32.9% |
| FY2024 | -$20.3M | +8.3% |
| FY2023 | -$22.2M | +10.8% |
| FY2022 | -$24.8M | +2.8% |
| FY2021 | -$25.6M | -26.6% |
| FY2020 | -$20.2M | -8.8% |
| FY2019 | -$18.6M | -19.5% |
| FY2018 | -$15.5M | +6.0% |
| FY2017 | -$16.5M | -32.1% |
| FY2016 | -$12.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice